Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Blog

Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.

Page 9

Trial readouts

FIT-HF Semaglutide Trial Protocol

FIT-HF will compare semaglutide with intensive diet-based weight loss in 100 adults with obesity and reduced-ejection-fraction heart failure.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

GLP-1 Social Media Sourcing Survey

A 2026 survey tested which mock social posts shaped GLP-1 purchase choices. Its self-reported, online sample sets important limits on the findings.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Incretin Drugs for PCOS: 2026 Review

A 2026 review maps semaglutide, tirzepatide and retatrutide for PCOS, but reproductive evidence still trails weight-loss data.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Oral Obesity Drugs: 2026 Review

A German review compares oral semaglutide and orforglipron, while trial data show convenience does not remove efficacy or safety tradeoffs.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Semaglutide Blood Pressure Meta-analysis

A seven-trial meta-analysis found a modest systolic blood-pressure reduction with subcutaneous semaglutide versus placebo.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Semaglutide and Muscle Cells: New Study

A six-donor cell study found no direct muscle atrophy signal from semaglutide, but it cannot settle what happens in people over time.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Semaglutide Nanoparticles in Oral Cancer

A preclinical paper tested semaglutide-loaded nanoparticles in oral cancer models, but it provides no evidence for cancer treatment in people.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Tirzepatide and Gastric Remnant Necrosis

A case report raises tirzepatide as one possible contributor to gastric remnant necrosis after bypass, but it cannot establish causality.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Tirzepatide and Sleep Apnea Evidence

A 2026 narrative review links tirzepatide with respiratory and metabolic changes in sleep apnea. The underlying trials define what is established.

6 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Country deep-dive

Semaglutide import rules in Denmark

Denmark permits some personal semaglutide imports, but lawful sale, exact product identity and personal-use records still matter.

5 Nov 2026 · PeptideMethods Editorial Team · 8 min read
Trial readouts

GLP-1 drugs and bone: what 12 trials show

A 2026 meta-analysis found a small lumbar-spine signal but no eligible tirzepatide or semaglutide 2.4 mg bone trials.

5 Nov 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

LEAP-BED Semaglutide and Tirzepatide Pilot

A 41-person prospective pilot found an early symptom signal, but its small nonrandomized comparison cannot establish treatment efficacy.

5 Nov 2026 · PeptideMethods Editorial Team · 4 min read